Red light diligence
This is the standard a red-light supplier satisfies in writing before purchase, and the basis on which an installed unit is verified. Throughout, what is stated is kept apart from what is verified: a figure is credible only when it is independently measured and given at the point of use, where a member actually sits, not at the diode.
The verdict is green, amber or red. A manufacturer with a real product answers these quickly, and hesitation, redirection to marketing language, or commercial sensitivity, is itself the verdict.

What is the peak wavelength of each emitter, and the full spectral power distribution? What proportion of total optical output falls within the intended therapeutic bands, and who measured it, on what instrument?
Photobiomodulation is wavelength-specific, acting on defined chromophores such as cytochrome c oxidase. Output outside the active bands is heat and marketing, not dose.
What is the irradiance, in mW/cm squared, at the actual distance a user sits or lies, stating that distance, not at the LED surface? How was it measured, with what calibrated sensor, and how does it vary across the treatment area?
Dose is irradiance multiplied by time. Irradiance falls sharply with distance, so a figure quoted at the diode is meaningless for a member positioned away from it. This is the single most gamed number in the category.
What target dose, in J/cm squared, do the protocols deliver, for what outcome, and how long does it take to reach that dose at the stated distance? What is the evidence the dose is effective and not into the inhibitory range?
The response is biphasic: too little does nothing, too much can inhibit. Dose is derivable from real irradiance and time, or it is asserted.
What is the beam angle, and the irradiance map across the treatment plane from edge to centre? Over what area is the stated irradiance actually delivered?
A high centre reading over a small hotspot is not whole-body treatment. Uniformity determines whether the body receives the claimed dose at all.
What is the per cent flicker, the flicker index and the flicker frequency, and what driver is used, constant current or pulse-width modulation?
Poor drivers introduce flicker linked to headache, eye strain and discomfort. It is invisible to the eye and corrosive to a recovery proposition.
What are the surface and skin temperatures during use, and how much of the claimed benefit is photobiological rather than thermal?
Warmth feels therapeutic and drives placebo. A unit whose effect is mostly heat is an expensive heat lamp, so the verdict separates light dose from warmth.
What is the photobiological safety classification under IEC 62471, and the risk group? What eye protection is required, and what is the exposure guidance for unsupervised commercial use?
High-irradiance near-infrared carries retinal and thermal eye risk. An unsupervised model, where a member takes a code and goes in, raises the bar on safety documentation.
How does optical output change over the service life, and at what point are emitters replaced to maintain dose? Is output, not only parts, covered by warranty, and what is the re-measurement interval?
Irradiance falls as diodes age, so a unit correct on day one silently under-doses years later. This is the precise drift the annual verification exists to catch.
What is the actual measured optical power, against the advertised figure? What emitter grade and binning tolerance are used, and where and to what standard is it manufactured?
Advertised wattage is routinely the sum of theoretical emitter maxima, not delivered output. Binning tolerance decides whether units are consistent site to site.
Are the spectral, irradiance and flicker figures verified by an independent accredited laboratory, and will the reports be provided? What certifications does the device hold?
Self-reported figures are a claim, not a fact. Independent verification is what separates a credible manufacturer from a confident one.
For each claimed benefit, what evidence supports it at this device's actual output parameters, rather than generic photobiomodulation literature run at a different dose and wavelength?
Most red-light marketing borrows the credibility of clinical studies conducted at parameters the device does not deliver. Claims match the device's real dose, or they are withdrawn.
Assigning the verdict
The pattern matters more than any single answer. Where this set escalates to on-site verification, the questions above become the measurement plan: the same parameters, read in the room with calibrated instruments.
How a verdict is reached sets out the wider framework, and the modality taxonomy places this channel among the other nine.